11 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... America #HFrEF #HeartFailure ... #Management #CHF ... ACCAHA2017 #cardiology #treatment ... #algorithm #sCHF
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Osteoporosis Treatment ... Algorithm Evaluate ... • Recommend pharmacologic ... #Osteoporosis #AACE
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
resynchronization therapy; DM, diabetes ... ventricular hypertrophy; MCS ... #CHF #Congestive ... #HeartFailure # ... Stages #ACCAHA #Algorithm
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... Guidelines: • ACC ... iron #deficiency #CHF ... #HFrEF #heartfailure
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... /ambcarerx #CHF ... #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment
Flowchart to diuretic use in acute heart failure.

(A) Congestion with volume overload. 

(B) Treatment algorithm after
(B) Treatment algorithm ... administered either as ... administration, once a day dosing ... Diuretic #Diuresis #CHF ... #HeartFailure #
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... Jcortesizaguirr #HFrEF #heartfailure ... management #cardiology #pharmacology ... #sCHF
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... posts for the COPD treatment ... algorithm). ... are the normal dosing ... Naming #Names #Pharmacology
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... oral suspension DOSING ... with CKD, HF, or diabetes ... ACE inhibitors, ... #Hyperkalemia #Pharmacology
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Revascularization, treatment ... NSAlDs, ACE-inhibitors ... #Checklist #CHF ... #Cardiogenic #HeartFailure